drugset / Trial / NCT00987662
Irbesartan Versus Amlodipine: The OBI Study
RandomizedParallel-groupOpen-labelDiagnostic
Summary
Objective: 1. To study the effectiveness of irbesartan 300mg and amlodipine 10 mg in 24h ambulatory blood pressure values in obese subjects 2. To study the drug specific effect in arterial stiffness 3. To study possible drug mechanisms in obesity (reduction of central adiposity and changing the ratio of leptin to adiponectin)
Timeline
- Start
- 2012-01
- Primary completion
- 2013-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | 10 mg | — |
| Comparator | Irbesartan | Small molecule | 300 mg | — |
| Comparator | Hydrochlorothiazide | Unknown | 12.5 mg | — |